© 2025 Historical Returns. All rights reserved.

Historical Returns of Sun Pharmaceutical Industries Limited

From 1996 to 2024 (28 years), the stock price grew by 111,154.60%. Dividends were issued 35 times and stock splits occurred 5 times during this period.

Find Out How Much Your Investment in Sun Pharmaceutical Industries Limited Could Have Grown.

Invested

Bought

Investment Period
Start Date
End Date
Sun Pharmaceutical Industries Limited data starting From 1, 1996

Results

Capital Growth

Between , your total capital would have grown XXXX.

Dividends

You would have earned XXXX in dividends.

Stock Splits

Your total number of shares after stock splits and bonus shares would have grown from XXXX.

Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited (Sun Pharma) is India’s largest pharmaceutical company and a global leader in generic medicines. Established in 1983, Sun Pharma is renowned for its high-quality, affordable medications and a robust product portfolio that spans multiple therapeutic areas, including cardiology, neurology, gastroenterology, and dermatology.

The company operates in over 100 countries, serving millions of patients worldwide. Sun Pharma’s focus on innovation and research is evident in its extensive R&D facilities, which develop complex generics, specialty medicines, and novel drug delivery systems.

Sun Pharma is also a leader in specialty pharmaceuticals, offering advanced therapies in oncology, ophthalmology, and immunology. The company’s commitment to patient care and accessibility drives its mission to make healthcare more affordable and inclusive.

With a strong emphasis on sustainability and community welfare, Sun Pharmaceutical Industries Limited continues to set benchmarks in the pharmaceutical industry, delivering value to patients and healthcare providers globally.